Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Redhill Biopharma Ltd. ADR (NASDAQ: RDHL) closed at $4.25 down -11.83% from its previous closing price of $4.82. In other words, the price has decreased by -$11.83 from its previous closing price. On the day, 2.42 million shares were traded.
Ratios:
For a deeper understanding of Redhill Biopharma Ltd. ADR’s stock, let’s take a closer look at its various ratios.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on August 31, 2021, initiated with a Overweight rating and assigned the stock a target price of $22.
On May 18, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $23.
Stock Price History:
Over the past 52 weeks, RDHL has reached a high of $20.27, while it has fallen to a 52-week low of $4.72. The 50-Day Moving Average of the stock is -29.87%, while the 200-Day Moving Average is calculated to be -50.49%.
Shares Statistics:
A total of 1.27M shares are outstanding, with a floating share count of 1.27M. Insiders hold about 0.00% of the company’s shares, while institutions hold 6.59% stake in the company.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
